Neuraltus Enrolls Nearly Half of Patients in Phase 2 Confirmation Trial of NP001 for
Neuraltus Enrolls Nearly Half of Patients in Phase 2 Confirmation Trial of NP001 for ALS
ALS Treatment Developer Neuraltus Enrolls Patients in Phase 2 Trial |
All times are GMT -5. The time now is 03:26 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.